ZIGNIFEX Trademark

Trademark Overview


On Wednesday, May 14, 2025, a trademark application was filed for ZIGNIFEX with the United States Patent and Trademark Office. The USPTO has given the ZIGNIFEX trademark a serial number of 99184468. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Monday, August 18, 2025. This trademark is owned by Merck Sharp & Dohme B.V.. The ZIGNIFEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccin...
zignifex

General Information


Serial Number99184468
Word MarkZIGNIFEX
Filing DateWednesday, May 14, 2025
Status645 - FINAL REFUSAL - MAILED
Status DateMonday, August 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 14, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMerck Sharp & Dohme B.V.
Party Type10 - Original Applicant
Legal Entity Type26 - NOT AVAILABLE
AddressHaarlem 2031BN
NL

Trademark Events


Event DateEvent Description
Wednesday, May 14, 2025NEW APPLICATION ENTERED
Wednesday, May 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 14, 2025APPLICATION FILING RECEIPT MAILED
Monday, July 21, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 21, 2025ASSIGNED TO EXAMINER
Monday, July 21, 2025LETTER OF SUSPENSION E-MAILED
Thursday, July 24, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, July 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 11, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 14, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 14, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 18, 2025PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, August 18, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, August 18, 2025FINAL REFUSAL WRITTEN
Monday, August 18, 2025FINAL REFUSAL E-MAILED
Monday, August 11, 2025NON-FINAL ACTION WRITTEN
Monday, July 21, 2025SUSPENSION LETTER WRITTEN
Thursday, July 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 11, 2025NON-FINAL ACTION E-MAILED